Epigenetic combination therapy as a tumo
โ
Sascha Venturelli; Sorin Armeanu; Anita Pathil; Chih-Jen Hsieh; Thomas S. Weiss;
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 259 KB
## Abstract ## BACKGROUND. Innovative epigenetic therapeutics comprise histone deacetylase inhibitors (HDACโI) and demethylating agents (DA). It was recently found that HDACโI compounds exhibit profound therapeutic activities against hepatocellular carcinoma (HCC). A comprehensive preclinical inve